about
SBRT: A viable option for treating adrenal gland metastasesCombined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting.Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancerErlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical resultsPhase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer.Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature.¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC.Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey.A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients.Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.The role of mammography after breast-conserving surgery and adjuvant chemotherapy.Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection.Whole-breast irradiation: a subgroup analysis of criteria to stratify for prone position treatment.The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO--Young Members Working Group (AIRO Giovani).Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer.Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy.Radiotherapy and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors in Renal Cancer.Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system.Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patientsAdding Ipsilateral V20 and V30 to Conventional Dosimetric Constraints Predicts Radiation Pneumonitis in Stage IIIA–B NSCLC Treated With Combined-Modality TherapyBeams Arrangement in Non-Small Cell Lung Cancer (NSCLC) According to PTV and Dosimetric Parameters Predictive of PneumonitisNeutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal AdenocarcinomaCombination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacyCombination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicitySafety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature reviewPositron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinomaConcurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: Preliminary assessment of toxicityPositron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysisHypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study
P50
Q28088346-C0601A1D-9CFB-487C-9F71-5FE110A932BAQ30248531-D90F9B51-CA49-4D70-A741-E305149C6DADQ36376503-FE45C2ED-1107-4BDC-9475-DEC8E5ED2DF6Q37105715-066B800B-9886-4FF7-8796-F4462179F227Q37738012-16C7E2D1-386C-46F6-B8C2-6EC1F89C9686Q38235333-F2E3DF9A-0B23-496C-909C-BAC6618D4F53Q38236058-DA45542A-609A-4853-8D90-88C372245941Q38692519-261B10E8-8CE2-4313-A64A-D97251A4601BQ40960607-5900E951-D7E4-40F0-83B8-A935889EF92CQ42227939-BE2A48EF-4182-4CBA-9D5C-AD9ADF5EA796Q43252125-6666EA85-08C7-4361-B40A-C511721B9165Q43618158-AC99EF25-3792-4AB1-991E-41F5A1E55B23Q43696599-55E52A2B-0F7B-4E8C-9BA3-DA00517B1BB6Q44391316-238B9A9B-B7DD-490A-8BB3-5F8F12ABCF80Q46497338-01C7FD6F-CDF9-4F49-AF12-EC5D5E5980C0Q52648515-96DA47DE-FFBB-47DF-B14B-D3C46B78B7B9Q53053615-63E6D02D-1ECC-4090-B4A9-AC174C41CDC8Q54120562-B606D72E-8F45-4783-B9D2-FDCA439C3CB4Q55331975-3D62B1A1-6C3A-4A65-AC14-5067583C72BDQ58581973-A0F366DD-91F9-472F-ADD5-084731B51303Q59789876-27928B8B-4097-489B-A04A-9146A24717F1Q62104267-17E83CCB-7EF3-4EE0-BFAB-095E69C9DF2BQ62104271-FDE13775-95E2-4AE6-B20E-E8B41E443BEFQ88552096-B927F3FF-7803-4793-A203-059E60AC902BQ91116022-BBAD346E-33D3-4730-B873-3A637319BF84Q91116024-BA22F6EB-93B1-493A-91E3-990D2D1485E5Q91128957-D4B8E3D0-365C-4DDA-ABD0-300B031D5CB9Q91841348-8604D531-D0D8-42D4-9206-F230DAE97FBDQ91870551-BC7CE849-0A12-42BF-BF7D-63073227365CQ92116492-B1613319-1B8C-4EB0-A4C4-FD39380223E3Q92799004-29F94951-4C29-44B7-B93C-74033803926AQ93085918-76F82B7B-AF38-4FE3-832A-774F39D4D772Q93104828-1C70B620-4359-4A6B-8BB2-C4DCC9591A21
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michele Fiore
@ast
Michele Fiore
@en
Michele Fiore
@es
Michele Fiore
@sl
type
label
Michele Fiore
@ast
Michele Fiore
@en
Michele Fiore
@es
Michele Fiore
@sl
prefLabel
Michele Fiore
@ast
Michele Fiore
@en
Michele Fiore
@es
Michele Fiore
@sl
P106
P1153
55838511044
P31
P496
0000-0003-1889-4578